Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

Nav

General Info

Geography

Global

Time period covered

01/2013 - 12/2016

Data type

Scientific literature

Keywords

Cholesterol, Heart failure, Ischemic heart disease, Stroke

Citation

Authors

Journal

JAMA

Volume

316

Issue

Pages

2373-2384

Publication year

2016

Suggested citation

Nicholls SJ, Puri R, Anderson T, Ballantyne CM, Cho L, Kastelein JJ, Koenig W, Somaratne R, Kassahun H, Yang J, Wasserman SM, Scott R, Ungi I, Podolec J, Ophuis AO, Cornel JH, Borgman M, Brennan DM, Nissen SE. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. JAMA. 2016; 316(22): 2373-2384.

DOI

10.1001/jama.2016.16951

PMID

27846344

GHDx Entry last modified on: May 30, 2020

Header sites

Search form

Main menu

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

Nav